Xiamen Lp Pharm Co Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XIAMEN LP PHARM CO, and what generic and branded alternatives to XIAMEN LP PHARM CO drugs are available?
XIAMEN LP PHARM CO has five approved drugs.
There is one tentative approval on XIAMEN LP PHARM CO drugs.
Summary for Xiamen Lp Pharm Co
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Xiamen Lp Pharm Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiamen Lp Pharm Co | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212797-002 | Jun 11, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Xiamen Lp Pharm Co | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212797-001 | Jun 11, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Xiamen Lp Pharm Co | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 213985-003 | Oct 11, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Xiamen Lp Pharm Co | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209757-001 | Nov 20, 2017 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
